Notice of final decisions to amend (or not amend) the current Poisons Standard in relation to Psilocybin and MDMA
Published
Notice of final decisions to amend (or not amend) the current Poisons Standard
This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS, this notice publishes the:
- decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR;
- reasons for those final decisions; and
- date of effect of those decisions.
Final decisions and reasons
- Notice of final decisions - ACMS #32, November 2020 (pdf,365kb)
- Notice of final decisions - ACMS #32, November 2020 (docx,109kb)
We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au.
Contents
- 1 Notice of final decisions to amend (or not amend) the current Poisons Standard
- 2 Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #32, November 2020)
- 2.1 Final decision in relation to psilocybin
- 2.2 Final decision in relation to N,α-Diemthyl-3,4-(methylenedioxy)phenylethylamine (MDMA)